Peer review reports
From: The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial
Original Submission |
22 Feb 2013 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
13 Apr 2013 |
Author responded |
Author comments - hui wang
|
Resubmission - Version 4 |
13 Apr 2013 |
Submitted |
Manuscript version 4
|
26 Apr 2013 |
Author responded |
Author comments - hui wang
|
Resubmission - Version 5 |
26 Apr 2013 |
Submitted |
Manuscript version 5
|
Publishing |
9 May 2013 |
Editorially accepted |
|
5 Jun 2013 |
Article published |
10.1186/1745-6215-14-165
|
Learn about peer review